Companies › Wilson Therapeutics

Wilson Therapeutics

Healthcare 📍 Stockholm, Sweden 👥 1001-5000 employees 💰 $40.0M raised 📅 Founded 2012

Wilson Therapeutics AB is a privately-held biopharmaceutical company focused on developing novel treatments for Wilson Disease, a rare genetic disease that effects approximately 1 in 15,000. Wilson Therapeutics was founded in 2012. Wilson Therapeutics’ lead compound, WTX101, is the proprietary bis-choline salt of tetr

📊 Company Overview

Sector
Healthcare
Country
Sweden
Employees
1001-5000
Total Raised · Venture
$40.0M
Founded
2012
Cloud
Unknown

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider
Workspace🔒 Subscribers only
CDN🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$11M $27M / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms🔒 Subscribers only
Analytics & CRM🔒 Subscribers only
CMS / Platform🔒 Subscribers only
Frontend Stack🔒 Subscribers only

Detected from Wilson Therapeutics's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

Data detected 2026-06-13 · Methodology · Suggest a correction